These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 11440350

  • 1. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy.
    Montenegro MA, Cendes F, Noronha AL, Mory SB, Carvalho MI, Marques LH, Guerreiro CA.
    Epilepsia; 2001 Apr; 42(4):539-42. PubMed ID: 11440350
    [Abstract] [Full Text] [Related]

  • 2. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group.
    Epilepsia; 1991 Apr; 32(3):407-16. PubMed ID: 2044502
    [Abstract] [Full Text] [Related]

  • 3. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674
    [Abstract] [Full Text] [Related]

  • 4. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
    Contin M, Riva R, Albani F, Baruzzi AA.
    Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center.
    Montenegro MA, Arif H, Nahm EA, Resor SR, Hirsch LJ.
    Clin Neuropharmacol; 2008 Dec; 31(6):333-8. PubMed ID: 19050410
    [Abstract] [Full Text] [Related]

  • 6. Clobazam in the treatment of epilepsy: a review of the literature.
    Remy C.
    Epilepsia; 1994 Dec; 35 Suppl 5():S88-91. PubMed ID: 8039479
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of clobazam as add-on therapy in children with refractory focal epilepsy.
    da Silveira MR, Montenegro MA, Franzon RC, Guerreiro CA, Guerreiro MM.
    Arq Neuropsiquiatr; 2006 Sep; 64(3B):705-10. PubMed ID: 17057871
    [Abstract] [Full Text] [Related]

  • 8. Clobazam as a new antiepileptic drug and clorazepate dipotassium as an alternative antiepileptic drug in Japan.
    Sugai K.
    Epilepsia; 2004 Sep; 45 Suppl 8():20-5. PubMed ID: 15610190
    [Abstract] [Full Text] [Related]

  • 9. Clobazam in long-term epilepsy treatment: sustained responders versus those developing tolerance.
    Singh A, Guberman AH, Boisvert D.
    Epilepsia; 1995 Aug; 36(8):798-803. PubMed ID: 7635098
    [Abstract] [Full Text] [Related]

  • 10. Clobazam as add-on therapy in children with epileptic encephalopathy.
    Silva RC, Montenegro MA, Guerreiro CA, Guerreiro MM.
    Can J Neurol Sci; 2006 May; 33(2):209-13. PubMed ID: 16736732
    [Abstract] [Full Text] [Related]

  • 11. Clobazam as add-on therapy for temporal lobe epilepsy and hippocampal sclerosis.
    Montenegro MA, Ferreira CM, Cendes F, Li LM, Guerreiro CA.
    Can J Neurol Sci; 2005 Feb; 32(1):93-6. PubMed ID: 15825553
    [Abstract] [Full Text] [Related]

  • 12. Stiripentol: efficacy and tolerability in children with epilepsy.
    Perez J, Chiron C, Musial C, Rey E, Blehaut H, d'Athis P, Vincent J, Dulac O.
    Epilepsia; 1999 Nov; 40(11):1618-26. PubMed ID: 10565591
    [Abstract] [Full Text] [Related]

  • 13. Use of clobazam for the treatment of refractory complex partial seizures.
    Shimizu H, Kawasaki J, Yuasa S, Tarao Y, Kumagai S, Kanemoto K.
    Seizure; 2003 Jul; 12(5):282-6. PubMed ID: 12810340
    [Abstract] [Full Text] [Related]

  • 14. Long-term use of clobazam in Lennox-Gastaut syndrome: experience in a single tertiary epilepsy center.
    Lee EH, Yum MS, Choi HW, Ko TS.
    Clin Neuropharmacol; 2013 Jul; 36(1):4-7. PubMed ID: 23334068
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB.
    Kinoshita M, Ikeda A, Begum T, Terada K, Shibasaki H.
    J Neurol Sci; 2007 Dec 15; 263(1-2):44-8. PubMed ID: 17588610
    [Abstract] [Full Text] [Related]

  • 16. Clobazam for refractory focal epilepsy. A controlled trial.
    Schmidt D, Rohde M, Wolf P, Roeder-Wanner U.
    Arch Neurol; 1986 Aug 15; 43(8):824-6. PubMed ID: 3089202
    [Abstract] [Full Text] [Related]

  • 17. CLB add-on treatment in patients with epileptic encephalopathy: a single center experience with long-term follow-up.
    Türkdoğan D, Öztürk G.
    Acta Neurol Belg; 2022 Feb 15; 122(1):51-57. PubMed ID: 33782854
    [Abstract] [Full Text] [Related]

  • 18. Clobazam for treatment of intractable epilepsy: a critical assessment.
    Schmidt D.
    Epilepsia; 1994 Feb 15; 35 Suppl 5():S92-5. PubMed ID: 8039480
    [Abstract] [Full Text] [Related]

  • 19. Effects of clobazam for treatment of refractory status epilepticus.
    Madžar D, Geyer A, Knappe RU, Gollwitzer S, Kuramatsu JB, Gerner ST, Hamer HM, Huttner HB.
    BMC Neurol; 2016 Oct 21; 16(1):202. PubMed ID: 27769254
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
    Savage TE, Sourbron J, Bruno PL, Skirvin LA, Wolper ES, Anagnos CJ, Thiele EA.
    Epilepsy Res; 2020 Feb 21; 160():106263. PubMed ID: 31923763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.